Important Information Regarding Rhopressa

Posted in Latest News on June 26, 2018.

During the June 22, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.

Important note, Rhopressa, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided.



More Latest News

Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions
Continue reading


Potential Spam Alert
November 18, 2020

The Department of Health, Division of Medical Quality Assurance is warning Florida health care practitioners about fraudulent calls that have been received by multiple licensees.
Continue reading